INVESTIGATION OF NEUROPROTECTIVE TARGETS FOR PARKINSON’S DISEASE AND THEIR ROLE IN PATHOPHYSIOLOGY WITH A SECONDARY LOOK AT A MOLECULAR TARGET FOR SCHIZOPHRENIA